Obesity could decrease the diagnostic performance of ultrasound, which in turn, reduce the cost-effectiveness of ultrasound ± AFP, but the strategies remained cost-effective. The gene discussed is AFP; the disease is obesity due to melanocortin 4 receptor deficiency.